Additional file 1: Tables S1.
(A) Baseline serogenetic findings and follow-up in females with confirmed abnormal transglutaminase 2/deamidated gliadin peptide (TG2/DGP) lgA/lgG when recruited 1994 to 1997. (B) Baseline serogenetic findings and follow-up in men with confirmed abnormal composite TG2/DGP lgA/lgG at recruitment during the period 2001 to 2006.
Format: TIFF Size: 1.5MB Download file
Anderson et al. BMC Medicine 2013 11:188 doi:10.1186/1741-7015-11-188